| Andria Auger, FNP-BC | |
|
22 Keewaydin Dr, Salem, NH 03079-2839 | |
| (603) 685-6977 | |
| Not Available |
| Full Name | Andria Auger |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 22 Keewaydin Dr, Salem, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174196182 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Exeter Hospital Inc | Exeter, NH | Hospital |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Convenientmd Llc | 2062667033 | 81 |
News Archive
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Physicists and engineers at Case Western Reserve University have developed an optical sensor, based on nanostructured metamaterials, that's 1 million times more sensitive than the current best available-one capable of identifying a single lightweight molecule in a highly dilute solution.
ConvaTec, a world-leading provider of medical technologies for community and hospital care, today announced that it has made an initial donation of more than $400,000 in medical supplies to rescue and relief efforts in Haiti, following the devastating earthquake that hit that nation last week.
Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.
› Verified 4 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101202000996 |
News Archive
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Physicists and engineers at Case Western Reserve University have developed an optical sensor, based on nanostructured metamaterials, that's 1 million times more sensitive than the current best available-one capable of identifying a single lightweight molecule in a highly dilute solution.
ConvaTec, a world-leading provider of medical technologies for community and hospital care, today announced that it has made an initial donation of more than $400,000 in medical supplies to rescue and relief efforts in Haiti, following the devastating earthquake that hit that nation last week.
Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.
› Verified 4 days ago
| Entity Name | Convenientmd Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528330180 PECOS PAC ID: 2062667033 Enrollment ID: O20130410000222 |
News Archive
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Physicists and engineers at Case Western Reserve University have developed an optical sensor, based on nanostructured metamaterials, that's 1 million times more sensitive than the current best available-one capable of identifying a single lightweight molecule in a highly dilute solution.
ConvaTec, a world-leading provider of medical technologies for community and hospital care, today announced that it has made an initial donation of more than $400,000 in medical supplies to rescue and relief efforts in Haiti, following the devastating earthquake that hit that nation last week.
Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andria Auger, FNP-BC 360 Us Highway 1 Byp Unit 102, Portsmouth, NH 03801-7105 Ph: (603) 410-6700 | Andria Auger, FNP-BC 22 Keewaydin Dr, Salem, NH 03079-2839 Ph: (603) 685-6977 |
News Archive
A new analysis of how people prioritize their attention when determining safety and danger in busy settings, such as crossing a road, suggests that a person will pay more attention to something if they learn it is associated with danger.
Physicists and engineers at Case Western Reserve University have developed an optical sensor, based on nanostructured metamaterials, that's 1 million times more sensitive than the current best available-one capable of identifying a single lightweight molecule in a highly dilute solution.
ConvaTec, a world-leading provider of medical technologies for community and hospital care, today announced that it has made an initial donation of more than $400,000 in medical supplies to rescue and relief efforts in Haiti, following the devastating earthquake that hit that nation last week.
Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.
› Verified 4 days ago
Thomas Ryan Breslin, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 14 Keewaydin Dr Ste A, Salem, NH 03079 Phone: 800-930-5956 | |
Charlene Berube, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 23 Stiles Rd, Suite 213, Salem, NH 03079 Phone: 603-898-9834 | |
Lynda Torento, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6b Galway Ln, Salem, NH 03079 Phone: 603-688-7588 | |
Audrey Morgan, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 159 N Broadway, Salem, NH 03079 Phone: 603-893-4119 | |
Mr. Anthony G Haralabatos, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 59 Stiles Rd 104, Salem, NH 03079 Phone: 781-526-6447 | |
Keirsten Assad, C.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Stiles Rd Ste 202, Salem, NH 03079 Phone: 978-479-1892 | |
Brooke Guthrie, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 18 Keewaydin Dr, Salem, NH 03079 Phone: 603-898-4269 |